MY33-3
MY33-3 is a potent and selective inhibitor of receptor protein tyrosine phosphatase (RPTP) β/ζ, with an IC50 of ~0.1 μM. MY33-3 also inhibits PTP-1B (IC50 ~0.7 μM) . MY33-3 can reduce ethanol consumption and alleviate Sevoflurane-induced neuroinflammation and cognitive dysfunction[1][2][3].
Product Specifications
CAS Number
2204280-41-9
UNSPSC
12352005
Target
Phosphatase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/my33-3.html
Purity
99.53
Solubility
DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
FC(SC1=CC=C(CNCC2=CC=C(SC(F)(F)F)C=C2)C=C1)(F)F
Molecular Formula
C16H13F6NS2
Molecular Weight
397.40
References & Citations
[1]Fernández-Calle R, et, al. Pharmacological inhibition of Receptor Protein Tyrosine Phosphatase β/ζ (PTPRZ1) modulates behavioral responses to ethanol. Neuropharmacology. 2018 Jul 15;137:86-95. |[2]Fernández-Calle R, et, al. Role of RPTPβ/ζ in neuroinflammation and microglia-neuron communication. Sci Rep. 2020 Nov 20;10 (1) :20259. |[3]Mao S, et, al. Pleiotrophin Potentiates Sevoflurane Anesthesia-induced Learning Deficits in Mice. J Mol Neurosci. 2022 Jan;72 (1) :48-55.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC942831-100 1x 100 µL
DOG-1 / TMEM16A (Gastrointestinal Stromal Tumor Marker) (DG1/2831R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC610877-500 1x 500 µL
CD99 (MIC2/877), CF660R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
MTW08F4-PAG/W 10x 96 Well Plates
Protein A/G Coated - 96 well plates - 8 Well Strips on 12 x 8 frame - White PS
Sign In for Pricing
View Details